Showing results (381-390 of 782) with videos related to

Sort By:
Pageof 79
The Lancet. HIV|December 4, 2022
The effects of intimate partner violence on women's risk of HIV acquisition and engagement in the HIV treatment and care cascade: a pooled analysis of nationally representative surveys in sub-Saharan AfricaSalome Kuchukhidze, Dimitra Panagiotoglou, Marie-Claude Boily, et al.
The Lancet. HIV|November 25, 2022
Advanced HIV disease and health-related suffering-exploring the unmet need of palliative careAjay Rangaraj, Stephen Connor, Richard Harding, et al.
The Lancet. HIV|July 29, 2022
72 weeks post-partum follow-up of dolutegravir versus efavirenz initiated in late pregnancy (DolPHIN-2): an open-label, randomised controlled studyThokozile R Malaba, Irene Nakatudde, Kenneth Kintu, et al.
The Lancet. HIV|July 29, 2022
Viral suppression and HIV-1 drug resistance 1 year after pragmatic transitioning to dolutegravir first-line therapy in Malawi: a prospective cohort studyBirgit Schramm, Elvis Temfack, Diane Descamps, et al.
The Lancet. HIV|July 29, 2022
Temporal changes in paediatric and adolescent HIV outcomes across the care continuum in Zambia: an interrupted time-series analysisCarolyn Bolton-Moore, Izukanji Sikazwe, Mwangelwa Mubiana-Mbewe, et al.
The Lancet. HIV|July 17, 2019
Long-acting or extended-release antiretroviral products for HIV treatment and prevention in infants, children, adolescents, and pregnant and breastfeeding women: knowledge gaps and research prioritiesSharon Nachman, Claire L Townsend, Elaine J Abrams, et al.
The Lancet. HIV|April 15, 2024
Pharmacokinetics and safety of coformulated bictegravir, emtricitabine, and tenofovir alafenamide in children aged 2 years and older with virologically suppressed HIV: a phase 2/3, open-label, single-arm studyCarina A Rodriguez, Eva Natukunda, Renate Strehlau, et al.
The Lancet. HIV|April 3, 2016
Virological failure in patients with HIV-1 subtype C receiving antiretroviral therapy: an analysis of a prospective national cohort in SwedenAmanda Häggblom, Veronica Svedhem, Kamalendra Singh, et al.
The Lancet. HIV|April 3, 2016
Retention in care during the first 3 years of antiretroviral therapy for women in Malawi's option B+ programme: an observational cohort studyAndreas D Haas, Lyson Tenthani, Malango T Msukwa, et al.
The Lancet. HIV|April 3, 2016
Community viral load, antiretroviral therapy coverage, and HIV incidence in India: a cross-sectional, comparative studySunil Suhas Solomon, Shruti H Mehta, Allison M McFall, et al.
Pageof 79